FDA is incapable of protecting US "against another Vioxx".
作者信息
Lenzer Jeanne
出版信息
BMJ. 2004 Nov 27;329(7477):1253. doi: 10.1136/bmj.329.7477.1253.
Abstract
摘要
相似文献
1
FDA is incapable of protecting US "against another Vioxx".美国食品药品监督管理局无法保护美国“免受另一次万络事件的影响”。
BMJ. 2004 Nov 27;329(7477):1253. doi: 10.1136/bmj.329.7477.1253.
2
The Vioxx debacle revisited.再谈万络事件。
Am J Med. 2005 Sep;118(9):1056-7; author reply 1057. doi: 10.1016/j.amjmed.2005.04.024.
3
The Vioxx debacle revisited.再谈万络事件。
Am J Med. 2005 Sep;118(9):1058. doi: 10.1016/j.amjmed.2005.06.045.
4
The vexations of Vioxx.万络的困扰
CMAJ. 2006 Feb 14;174(4):444-5. doi: 10.1503/cmaj.060041.
5
Vioxx: lessons for Health Canada and the FDA.万络：给加拿大卫生部和美国食品药品监督管理局的教训
CMAJ. 2005 Jan 4;172(1):5, 7. doi: 10.1503/cmaj.045206.
6
New use approved for Vioxx.
FDA Consum. 2002 Jul-Aug;36(4):3.
7
Crisis deepens at the US Food and Drug Administration.美国食品药品监督管理局的危机加深。
BMJ. 2004 Dec 4;329(7478):1308. doi: 10.1136/bmj.329.7478.1308.
8
Despite warnings, drug giant took long path to Vioxx recall.尽管收到警告，制药巨头仍在很长时间后才召回万络。
N Y Times Web. 2004 Nov 14:A1, A32.
9
Merck withdraws Vioxx; FDA issues public health advisory.默克公司撤回万络；美国食品药品监督管理局发布公共卫生咨询。
FDA Consum. 2004 Nov-Dec;38(6):11.
10
How to avoid future Vioxx-type scandals.
Prescrire Int. 2005 Jun;14(77):115-7.
引用本文的文献
1
Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications.透视药物警戒：药物撤市、数据挖掘及政策影响
F1000Res. 2019 Dec 16;8:2109. doi: 10.12688/f1000research.21402.1. eCollection 2019.
2
Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review.人乳头瘤病毒（HPV）疫苗行业临床试验计划和非行业资助研究索引：系统评价中解决报告偏倚的必要基础。
Syst Rev. 2018 Jan 18;7(1):8. doi: 10.1186/s13643-018-0675-z.
3
A framework for feature extraction from hospital medical data with applications in risk prediction.一种用于从医院医疗数据中提取特征并应用于风险预测的框架。
BMC Bioinformatics. 2014 Dec 30;15(1):425. doi: 10.1186/s12859-014-0425-8.
4
Access to regulatory data from the European Medicines Agency: the times they are a-changing.获取欧洲药品管理局监管数据的途径：正在发生变化。
Syst Rev. 2012 Oct 30;1:50. doi: 10.1186/2046-4053-1-50.
5
How the continuity of care document can advance medical research and public health.连续性护理文档如何促进医学研究和公共卫生。
Am J Public Health. 2012 May;102(5):e1-4. doi: 10.2105/AJPH.2011.300640. Epub 2012 Mar 15.
6
We need access to all data from all clinical trials.我们需要获取所有临床试验的全部数据。
Cochrane Database Syst Rev. 2011 Oct 4;2011(12):ED000035. doi: 10.1002/14651858.ED000035.
7
Why we need easy access to all data from all clinical trials and how to accomplish it.为什么我们需要方便地获取所有临床试验的数据，以及如何实现这一目标。
Trials. 2011 Nov 23;12:249. doi: 10.1186/1745-6215-12-249.
8
Today's challenges in pharmacovigilance: what can we learn from epoetins?药物警戒的今日挑战：我们能从红细胞生成素中学到什么？
Drug Saf. 2011 Apr 1;34(4):273-87. doi: 10.2165/11586350-000000000-00000.
9
Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings.植物源辣椒素类物质、非甾体抗炎药、胃肠道黏膜损伤及其在动物和人类中的预防相关性的跨学科综述
Inflammopharmacology. 2009 Jun;17(3):113-50. doi: 10.1007/s10787-009-0002-3. Epub 2009 Jun 26.
10
Drug safety information through the internet: the experience of an Italian website.通过互联网获取药物安全信息：一个意大利网站的经验
Drug Saf. 2009;32(3):245-53. doi: 10.2165/00002018-200932030-00007.
Zotero 插件